Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial. (linkinghub.elsevier.com)

Authors: Steinhardt LC … Seder RA Journal: The Lancet Published: 2026-04-25 DOI: https://doi.org/10.1016/S0140-6736(26)00258-8